Memory-chip maker swung to a profit and posted higher revenue in its fiscal first quarter, though shares fell after the company's outlook missed estimates. CVS ignored substantial evidence from ...

A promising new compound, HPH-15, may represent a significant breakthrough ... Compared to the widely used diabetes drug ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

Novo Nordisk made a submission to the U.S. Food and Drug Administration (FDA) nominating Novo Nordisk’s semaglutide ...

2024 was one of the most eventful years for the pharmaceutical, biotech, life sciences and medical marketing industries.

It’s likely to still be there at the end of the year, but by the time the final sales figures for 2024 are tallied up, Novo ...

In 2024, the most-read news articles published on the website of The American Journal of Managed Care® included FDA approvals ...

Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...

MORE medicines used for the treatment of cancer, diabetes and mental illness have been added to the list of value-added tax (VAT)-exempt drugs, according to the Bureau of Internal Revenue (BIR).

Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.